{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:39:33Z","timestamp":1791941973902,"version":"4.3.4"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T00:00:00Z","timestamp":1431993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"This research was supported, in part, by the DIR, NIDCR, a part of the Intramural Research Program of the NIH, DHHS."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>\u2003<\/jats:title>\n                  <jats:p>Synthetic human PTH 1-34 (hPTH 1-34) replacement therapy in hypoparathyroidism maintains eucalcemia and converts quiescent bone to high-turnover bone. However, the skeletal and metabolic effects of drug discontinuation have not been reported. Nine subjects with hypoparathyroidism received subcutaneous injections of hPTH 1-34 two to three times daily for 19.8 to 61.3 months and then transitioned back to calcium and calcitriol. Biochemistries and bone mineral density (BMD) by dual-energy X-ray absorptiometry (DXA) were assessed at baseline, while on treatment, and at follow-up 3 to 12 months after drug discontinuation. Two subjects developed hypocalcemia when hPTH 1-34 was abruptly discontinued. Thus, to avoid hypocalcemia, subjects were slowly weaned from hPTH 1-34 over several weeks. When hPTH 1-34 was stopped, subjects were requiring two to three times pretreatment doses of calcitriol and calcium to maintain blood calcium levels. Doses were gradually reduced over many weeks until calcium levels were stable on doses similar to baseline. Bone-specific alkaline phosphatase (BSAP), N-telopeptide (NTX), and osteocalcin (OC) increased significantly with hPTH 1-34; at follow-up, BSAP and NTX had returned to baseline while OC was still slightly elevated. During treatment, BMD was unchanged at the hip and lateral spine but declined at the anterior-posterior (AP) spine, radius, and total body. During weaning, BMD increased, with the hip and lateral spine exceeding pre-hPTH 1-34 values and the whole body returning to baseline. AP spine was increased non-significantly compared to baseline at follow-up. hPTH 1-34 must be gradually weaned in hypoparathyroid patients with high doses of oral medications given to avoid hypocalcemia. The transient increased requirements accompanied by increased BMD after long-term hPTH 1-34 therapy suggest a reversal of the expanded remodeling space favoring bone formation as the skeleton returns to a low-turnover state, reminiscent of the hungry bone syndrome. Further study and close monitoring is required to ensure safe transition to conventional therapy and to elucidate the physiological mechanism of this phenomenon. \u00a9 2015 American Society for Bone and Mineral Research.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/jbmr.2555","type":"journal-article","created":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T22:40:52Z","timestamp":1432075252000},"page":"2112-2118","source":"Crossref","is-referenced-by-count":29,"title":["Transient Increased Calcium and Calcitriol Requirements After Discontinuation of Human Synthetic Parathyroid Hormone 1-34 (hPTH 1-34) Replacement Therapy in Hypoparathyroidism"],"prefix":"10.1093","volume":"30","author":[{"given":"Rachel I","family":"Gafni","sequence":"first","affiliation":[{"name":"Skeletal Clinical Studies Unit (SCSU), Craniofacial and Skeletal Diseases Branch (CSDB), National Institute of Dental and Craniofacial Research (NIDCR)National Institutes of Health (NIH)BethesdaMDUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori C","family":"Guthrie","sequence":"additional","affiliation":[{"name":"Skeletal Clinical Studies Unit (SCSU), Craniofacial and Skeletal Diseases Branch (CSDB), National Institute of Dental and Craniofacial Research (NIDCR)National Institutes of Health (NIH)BethesdaMDUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn H","family":"Kelly","sequence":"additional","affiliation":[{"name":"Skeletal Clinical Studies Unit (SCSU), Craniofacial and Skeletal Diseases Branch (CSDB), National Institute of Dental and Craniofacial Research (NIDCR)National Institutes of Health (NIH)BethesdaMDUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth A","family":"Brillante","sequence":"additional","affiliation":[{"name":"Skeletal Clinical Studies Unit (SCSU), Craniofacial and Skeletal Diseases Branch (CSDB), National Institute of Dental and Craniofacial Research (NIDCR)National Institutes of Health (NIH)BethesdaMDUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Michele","family":"Christie","sequence":"additional","affiliation":[{"name":"Department of PediatricsKaiser PermanenteSpringfieldVAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Clinical Center (CC)\/Nuclear Medicine Department (NMD)National Institutes of Health (NIH)BethesdaMDUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A","family":"Yovetich","sequence":"additional","affiliation":[{"name":"Rho, Inc.Chapel HillNCUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"James","sequence":"additional","affiliation":[{"name":"Rho, Inc.Chapel HillNCUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T","family":"Collins","sequence":"additional","affiliation":[{"name":"Skeletal Clinical Studies Unit (SCSU), Craniofacial and Skeletal Diseases Branch (CSDB), National Institute of Dental and Craniofacial Research (NIDCR)National Institutes of Health (NIH)BethesdaMDUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,5,19]]},"reference":[{"issue":"12","key":"2024020319011847900_jbmr2555-bib-0001","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1210\/jc.2012-1808","article-title":"Long-term follow-up of patients with hypoparathyroidism","volume":"97","author":"Mitchell","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2024020319011847900_jbmr2555-bib-0002","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/BF00441552","article-title":"Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment","volume":"148","author":"Kruse","year":"1989","journal-title":"Eur J Pediatr."},{"issue":"2","key":"2024020319011847900_jbmr2555-bib-0003","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/8756-3282(95)00443-2","article-title":"Bone histomorphometry in hypoparathyroid patients treated with vitamin D","volume":"18","author":"Langdahl","year":"1996","journal-title":"Bone."},{"issue":"12)","key":"2024020319011847900_jbmr2555-bib-0004","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1359\/jbmr.080803","article-title":"Dynamic and structural properties of the skeleton in hypoparathyroidism","volume":"23","author":"Rubin","year":"2008","journal-title":"J Bone Miner Res."},{"issue":"6","key":"2024020319011847900_jbmr2555-bib-0005","first-page":"1617","article-title":"Bone mineral density in patients with chronic hypoparathyroidism","volume":"76","author":"Abugassa","year":"1993","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2024020319011847900_jbmr2555-bib-0006","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1532-5415.1990.tb05704.x","article-title":"The effect of hypoparathyroidism on the aging skeleton","volume":"38","author":"Shukla","year":"1990","journal-title":"J Am Geriatr Soc."},{"issue":"10","key":"2024020319011847900_jbmr2555-bib-0007","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1210\/jc.2003-030470","article-title":"Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects","volume":"88","author":"Chen","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2024020319011847900_jbmr2555-bib-0008","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2024020319011847900_jbmr2555-bib-0009","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1210\/jc.2009-2464","article-title":"Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium","volume":"95","author":"Winer","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2024020319011847900_jbmr2555-bib-0010","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jbmr.1627","article-title":"Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure","volume":"27","author":"Gafni","year":"2012","journal-title":"J Bone Miner Res."},{"issue":"8","key":"2024020319011847900_jbmr2555-bib-0011","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.1996.03540080053029","article-title":"Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism","volume":"276","author":"Winer","year":"1996","journal-title":"JAMA."},{"issue":"6","key":"2024020319011847900_jbmr2555-bib-0012","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1210\/jc.2006-2553","article-title":"The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race","volume":"92","author":"Kalkwarf","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2024020319011847900_jbmr2555-bib-0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2007.03162.x","article-title":"Primary hyperparathyroidism and the skeleton","volume":"69","author":"Mosekilde","year":"2008","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"5","key":"2024020319011847900_jbmr2555-bib-0014","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1359\/jbmr.070120","article-title":"New observations on bone quality in mild primary hyperparathyroidism as determined by quantitative backscattered electron imaging","volume":"22","author":"Roschger","year":"2007","journal-title":"J Bone Miner Res."},{"issue":"3","key":"2024020319011847900_jbmr2555-bib-0015","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1210\/jc.2002-021988","article-title":"Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment","volume":"88","author":"Misof","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2024020319011847900_jbmr2555-bib-0016","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/jbmr.1663","article-title":"Parathyroid hormone induces differentiation of mesenchymal stromal\/stem cells by enhancing bone morphogenetic protein signaling","volume":"27","author":"Yu","year":"2012","journal-title":"J Bone Miner Res."},{"issue":"11","key":"2024020319011847900_jbmr2555-bib-0017","doi-asserted-by":"crossref","first-page":"5713","DOI":"10.1210\/en.2008-0369","article-title":"Differentiation and proliferation of periosteal osteoblast progenitors are differentially regulated by estrogens and intermittent parathyroid hormone administration","volume":"149","author":"Ogita","year":"2008","journal-title":"Endocrinology."},{"issue":"2","key":"2024020319011847900_jbmr2555-bib-0018","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bone.2008.10.037","article-title":"Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts","volume":"44","author":"Jilka","year":"2009","journal-title":"Bone."},{"issue":"19","key":"2024020319011847900_jbmr2555-bib-0019","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med."},{"issue":"8","key":"2024020319011847900_jbmr2555-bib-0020","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1210\/jc.2008-2630","article-title":"Effects of teriparatide treatment and discontinuation in postmenopausal women and eugonadal men with osteoporosis","volume":"94","author":"Leder","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2024020319011847900_jbmr2555-bib-0021","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bone.2009.09.020","article-title":"Three dimensional cancellous bone structure in hypoparathyroidism","volume":"46","author":"Rubin","year":"2010","journal-title":"Bone."},{"issue":"5","key":"2024020319011847900_jbmr2555-bib-0022","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1359\/jbmr.081233","article-title":"PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation","volume":"24","author":"Theman","year":"2009","journal-title":"J Bone Miner Res."},{"key":"2024020319011847900_jbmr2555-bib-0023","first-page":"S128","article-title":"PTH increases bone turnover in hypoparathyroidism","volume":"23","author":"Rubin","year":"2008","journal-title":"J Bone Miner Res."},{"issue":"10","key":"2024020319011847900_jbmr2555-bib-0024","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/jbmr.470","article-title":"The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study","volume":"26","author":"Sikjaer","year":"2011","journal-title":"J Bone Miner Res."},{"key":"2024020319011847900_jbmr2555-bib-0025","first-page":"S12","article-title":"PTH reverses abnormal bone remodeling and structure in hypoparathyroidism","volume":"23","author":"Rubin","year":"2008","journal-title":"J Bone Miner Res."},{"issue":"11","key":"2024020319011847900_jbmr2555-bib-0026","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00198-009-1149-x","article-title":"Therapy of hypoparathyroidism with intact parathyroid hormone","volume":"21","author":"Rubin","year":"2010","journal-title":"Osteoporos Int."},{"issue":"4","key":"2024020319011847900_jbmr2555-bib-0027","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/jbmr.1493","article-title":"Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1-84): a randomized controlled study","volume":"27","author":"Sikjaer","year":"2012","journal-title":"J Bone Miner Res."},{"issue":"4","key":"2024020319011847900_jbmr2555-bib-0028","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study","volume":"1","author":"Mannstadt","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"2024020319011847900_jbmr2555-bib-0029","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1530\/EJE-12-0528","article-title":"Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature","volume":"168","author":"Witteveen","year":"2013","journal-title":"Eur J Endocrinol."},{"issue":"4","key":"2024020319011847900_jbmr2555-bib-0030","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/0002-9343(88)90100-3","article-title":"Hungry bone syndrome: clinical and biochemical predictors of its occurrence after parathyroid surgery","volume":"84","author":"Brasier","year":"1988","journal-title":"Am J Med."},{"issue":"6161","key":"2024020319011847900_jbmr2555-bib-0031","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/bmj.1.6161.450","article-title":"Value of 1-alpha-hydroxy vitamin D3 in treatment of primary hyperparathyroidism before parathyroidectomy","volume":"1","author":"Heath","year":"1979","journal-title":"Br Med J."},{"issue":"1","key":"2024020319011847900_jbmr2555-bib-0032","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2265.1981.tb02749.x","article-title":"Parathyroid function after parathyroidectomy: evaluation by measurement of urinary cAMP","volume":"15","author":"Spiegel","year":"1981","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"3","key":"2024020319011847900_jbmr2555-bib-0033","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00774-005-0680-x","article-title":"Bisphosphonate pretreatment attenuates hungry bone syndrome postoperatively in subjects with primary hyperparathyroidism","volume":"24","author":"Lee","year":"2006","journal-title":"J Bone Miner Metab."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.2555","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/30\/11\/2112\/56566981\/jbmr2555.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/30\/11\/2112\/56566981\/jbmr2555.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:54:24Z","timestamp":1710341664000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/30\/11\/2112-2118\/7599099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,19]]},"references-count":33,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,5,19]]},"published-print":{"date-parts":[[2015,11,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.2555","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,11,1]]},"published":{"date-parts":[[2015,5,19]]}}}